Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 7:46 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 889–912 of 2,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Neurodevelopmental Disorder Clear all

Conditions: Disruptive Behavior, Attention Deficit Hyperactivity Disorder, Oppositional Defiant Disorder, Conduct Disorder, Disruptive Behavior Disorder
Interventions: Mindful Parenting Program, MATCH BPT Program; Behavioral
Lead sponsor: New York University; Other
Eligibility: 6 Years to 11 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Attention Deficit Disorder With Hyperactivity, Conduct Disorder, Substance Abuse
Interventions: Adderall; Drug
Lead sponsor: Jeffrey Newcorn; Other
Eligibility: 7 Years to 12 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Insomnia Chronic, Autism Spectrum Disorder
Interventions: In-Person CBT for insomnia in children with autism, Remote CBT for insomnia in children with autism, Remote sleep hygiene and related education (SHARE) for insomnia in children with autism; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 6 Years to 12 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Tourette Syndrome
Interventions: Not listed
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 214 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 2
States / cities: Nashville, Tennessee

Conditions: Motor Coordination or Function; Developmental Disorder
Interventions: OT-SI; Other
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 59 Months to 107 Months
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Tourette Syndrome, Tic Disorders
Interventions: Habit reversal therapy, Supportive therapy; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 16 Years and older
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 3
States / cities: New Haven, Connecticut • Boston, Massachusetts • San Antonio, Texas

Conditions: Selective Mutism
Interventions: Remote Caregiver Training, Remote Intensive Group Behavioral Treatment (IGBT); Behavioral
Lead sponsor: Florida International University; Other
Eligibility: 4 Years to 10 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Voice Disorders, Muscle Tension Dysphonia, Speech Therapy
Interventions: Gargle Phonation, Water swallow; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 89 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 2
States / cities: Scottsdale, Arizona • Rochester, Minnesota

Conditions: Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder
Interventions: Methylphenidate, Placebo; Drug
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 8 Years to 21 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: ADHD
Interventions: ADHD Therapy; Device
Lead sponsor: Lumos Labs, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 194 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 5
States / cities: Jacksonville, Florida • Lakeland, Florida • Rochester Hills, Michigan + 2 more

Conditions: ADHD, Smoking
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 6 Years to 55 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Major Depressive Disorder, Attention-deficit Hyperactivity Disorder (ADHD)
Interventions: Not listed
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Neurodevelopmental Disorders
Interventions: Intensive therapy program; Other
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 4 Years to 15 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: ADH-Me Book and ADHD Informational Brochure, ADHD Informational Brochure Only; Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 7 Years to 10 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: No History of ADHD, Attention Deficit Hyperactivity Disorder (ADHD), Healthy Volunteer
Interventions: QbMobile; Device
Lead sponsor: Qbtech AB; Industry
Eligibility: 6 Years to 60 Years
Enrollment: 700 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 3
States / cities: San Jose, California • Largo, Florida • Orlando, Florida

Conditions: ADHD
Interventions: Vayarin, Placebo; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 60 Years
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Tourette Syndrome
Interventions: pramipexole immediate release (IR), Placebo; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 14
States / cities: Bradenton, Florida • Tampa, Florida • Columbus, Georgia + 10 more

Conditions: Hypoplastic Left Heart Syndrome
Interventions: Not listed
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 4 Years to 5 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Autism Spectrum Disorders
Interventions: Dextromethophan; Drug
Lead sponsor: Duke University; Other
Eligibility: 8 Years to 12 Years · Male only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Durham, North Carolina

Conditions: Autistic Spectrum Disorder, Patient Empowerment, Menstrual Discomfort
Interventions: Period Kit; Other
Lead sponsor: Tufts Medical Center; Other
Eligibility: 5 Years to 17 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Autism, Autism Spectrum Disorder High-Functioning, Developmental Disability, Child Development, Behavior, Child, Behavior, Social
Interventions: PRT for Adolescents; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 11 Years to 14 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Autistic Disorder, Autism
Interventions: Early intervention blending several tx approaches, w/ focus, Early intervention blending several treatment approaches; Behavioral
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 18 Months to 33 Months
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Neurofeedback, Cognitive Training, Waitlist Control; Behavioral · Other
Lead sponsor: Tufts Medical Center; Other
Eligibility: 6 Years to 12 Years
Enrollment: 104 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Quillivant Oral Suspension XR, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 6 Years to 12 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 2
States / cities: Irvine, California • Las Vegas, Nevada

Search by objective public record fields.

Mindful Parenting and Parent Training Program Study

Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder

Targeting Insomnia in School Aged Children With Autism Spectrum Disorder

Sensory Symptoms in Tourette Syndrome

A Multiple Baseline Design Study to Investigate the Effectiveness of OT-SI Using an Intensive Intervention Model

Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder

Evaluating an Online Adjunctive Support Following Intensive Services (OASIS) Strategy for Youth With Selective Mutism

A Study to Evaluate Effects of Gargle Phonation in Voice

Eye Tracking as a Predictor of Methylphenidate Response in Autism With ADHD

An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms

Family Risk Analysis of Substance Use in Attention Deficit Hyperactivity Disorder (ADHD) Youth Treated With Concerta

Measuring Adherence to Medication for Depression and Attention-deficit Hyperactivity Disorder

Experience With a Pediatric Summer Intensive Therapy Program

ADHD/Me Bibliotherapy Study

An Investigational Study Examining the Cross-Validation of QbMobile in ADHD and Normative Populations

Neurobiological Basis of Response to Vayarin in Adults With ADHD: an fMRI Study of Brain Activation Pre and Post Treatment

Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criteria

Near-infrared Spectroscopy (NIRS) Neurodevelopmental Outcomes

Cortical Metrics in Intervention Trials With Autism Spectrum Disorders

Development and Evaluation of "Period Kits" for Adolescents With Intellectual and Developmental Disabilities

PRT for Adolescents With High Functioning Autism

School- and Home-Based Early Intervention for Toddlers With Autism

Study of Computer Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder

Quillivant Oral Suspension (Quillivant XR) in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD)